Detalhe da pesquisa
1.
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
N Engl J Med
; 384(3): 229-237, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113295
2.
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med
; 385(15): 1382-1392, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260849
3.
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.
Clin Infect Dis
; 75(1): e440-e449, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718468
4.
A Dual-Platform Point-of-Care Test for Neurosyphilis Diagnosis.
Sex Transm Dis
; 48(5): 353-356, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843803
5.
A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.
Dig Dis Sci
; 66(6): 2084-2091, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648078
6.
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 325(7): 632-644, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475701
7.
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.
Clin Infect Dis
; 71(12): 3110-3117, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879782
8.
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 324(11): 1048-1057, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821939
9.
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate.
J Antimicrob Chemother
; 74(8): 2352-2359, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31093649
10.
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study.
AIDS Res Ther
; 16(1): 23, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464642
11.
Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
J Infect Dis
; 217(8): 1289-1297, 2018 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29304196
12.
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
BMC Infect Dis
; 15: 190, 2015 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884329
13.
Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
J Infect Dis
; 208(11): 1776-83, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23901097
14.
Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.
BMC Infect Dis
; 13: 269, 2013 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23741991
15.
The ATEAM study: Advances in technology to enhance PrEP adherence monitoring (ATEAM) among young men who have sex with men.
Clin Transl Sci
; 15(12): 2947-2957, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106611
16.
COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
PLoS One
; 17(9): e0273323, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083883
17.
Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?
Open Forum Infect Dis
; 8(12): ofab542, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877366
18.
A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2.
Infect Dis Ther
; 10(4): 1933-1947, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374951
19.
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.
Front Immunol
; 12: 790469, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34956222
20.
Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution.
AIDS Res Ther
; 7: 44, 2010 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156072